Research suggests that an enzyme could become a biomarker of response to tamoxifen therapy.
The researchers both head up the CRCL's hormone resistance, methylation, and breast cancer team.
Tamoxifen therapy is prescribed for a minimum period of 5 years. Despite this, 25% of women treated with tamoxifen relapse. Tamoxifen resistance is unique in that it occurs very late on, generally 10 to 15 years after starting treatment. This means that it's really important for us to identify predictive markers of the response to hormone therapy to adapt treatment as best we can.
The results of our study showed that high nuclear expression of PRMT5, specifically in the nuclei of breast cancer cells, is associated with a prolonged survival of tamoxifen-treated patients. Until now, we thought this enzyme had an oncogenic role when present in the cytoplasm. It turns out that it also has the opposite effect when acting within the nucleus, at least in this patient cohort: women with hormone-sensitive breast cancer treated with tamoxifen.
In the short term, yes, we could use this biomarker to better guide treatment choices at time of diagnosis. We have demonstrated the role of PRMT5 in response to tamoxifen by studying two cohorts of 900 patients with breast cancer receiving treatment at the Léon Bérard Center, Lyon. Before moving on to routine testing, we need to replicate these results in other cohorts, especially in high-risk patients with, for example, greater cell proliferation or those who experience relapse.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Turkish doctors in US develop vaccine to prevent breast cancer progressionThe vaccine, developed and tested in a laboratory for years, is being tested on 10 volunteers in a clinical trial.
Leer más »
After backlash, feds cancel plan that risked limiting breast reconstruction options after cancerThe Centers for Medicare and Medicaid Services backed off from a plan that could have curtailed access to a type of reconstructive surgery known as DIEP flap. Breast cancer patient advocates are relieved.
Leer más »
Hope.money (HOPE) Attempts to Bridge DeFi to CeFi and TradFi, Here's HowUnique stablecoin project Hope.money (HOPE) has released its three-phase roadmap with various end-user products and liquidity instruments
Leer más »
Nanoneedle breakthrough gives hope for cheaper cancer treatmentAustralian scientists have successfully found a way to inject beneficial genetic material into white blood cells in a world-first breakthrough that could significantly improve treatment options for certain types of blood cancer.
Leer más »
Late summer heat wave leaves 108M people under alerts with no relief in sightNearly 109 million Americans across the central U.S. from the Plains to the Midwest, and the Gulf Coast and Southeast are now under heat alerts that will last through at least Wednesday.
Leer más »
EUR/USD Forecast: Bulls give up, 1.0700 at sightThe EUR/USD pair trades at its lowest since mid-June as the Euro got hit by dismal local data. S&P Global released the preliminary estimates of the A
Leer más »